Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MTHFR and TYMS genotypes influence TPMT activity and its differential modulation in males and females.

Clinical biochemistry - 1 Jan 2010

Karas-Kuzelicki Natasa, Milek Miha, Mlinaric-Rascan Irena

Abstract excerpt

OBJECTIVES: TPMT catalyzes the deactivation of the cytostatic drug 6-mercaptopurine used in treatment of cancer. Patients with low levels of TPMT more often experience severe toxic effects when treated with standard doses of 6-mercaptopurine than patients with high levels who, in turn, may experi...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimetabolites, Antineoplastic
Share to Folic Acid
Share to Linkage Disequilibrium

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mercaptopurine

Share to Methylenetetrahydrofolate Reductase (NADPH2)

Share to Methyltransferases

Share to Sex Factors

Share to Thymidylate Synthase

Source

Identifiers

PMID: 19748501
DOI: 10.1016/j.clinbiochem.2009.09.003

Genes

TPMT
MTHFR
TYMS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19748501-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MTHFR and TYMS genotypes influence TPMT activity and its differential modulation in males and females.PMID 19748501Read ↗

From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity.Semantic proximity Read ↗

Thiopurine S-methyltransferase pharmacogenetics in a large-scale healthy Italian-Caucasian population: differences in enzyme activity.Semantic proximity Read ↗

Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

Determination of thiopurine S-methyltransferase (TPMT) activity by comparing various normalization factors: reference values for Estonian population using HPLC-UV assay.Semantic proximity Read ↗

Influence of variants in folate metabolism genes on 6-mercaptopurine induced toxicity during treatment for childhood acute lymphocytic leukemia.Semantic proximity Read ↗

Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond.Semantic proximity Read ↗

Interindividual variability in TPMT enzyme activity: 10 years of experience with thiopurine pharmacogenetics and therapeutic drug monitoring.Semantic proximity Read ↗

Thiopurine S-methyltransferase activity in Nigerians: phenotypes and activity reference values.Semantic proximity Read ↗

Identification of a novel thiopurine S-methyltransferase allele (TPMT*37).Semantic proximity Read ↗

Frequency of thiopurine S-methyltransferase (TPMT) alleles in southeast Iranian population.Semantic proximity Read ↗

Genetic variation in the MTHFR gene influences thiopurine methyltransferase activity.Semantic proximity Read ↗

Polymorphic variation in TPMT is the principal determinant of TPMT phenotype: A meta-analysis of three genome-wide association studies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.